Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer

Colorectal cancer (CRC) is a common malignancy that has both low 5-year survival and high prevalence. Immunotherapy has achieved impressive progress for treatment of CRC, but still faces huge challenges. Although large tumor suppressor 2 (LATS2) is well accepted to be related to cancer progression,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chengwen, Chen, Jianping, Liu, Yonghui, Ju, Shaoqing, Wang, Guihua, Wang, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810027/
https://www.ncbi.nlm.nih.gov/pubmed/34699318
http://dx.doi.org/10.1080/21655979.2021.1996513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810027/
https://www.ncbi.nlm.nih.gov/pubmed/34699318
http://dx.doi.org/10.1080/21655979.2021.1996513

Ejemplares similares